Related Experiment Video
Updated: Jun 19, 2026
05:39
Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids
Published on: April 5, 2024
[Radiation-induced and therapy-related AML/MDS]
1Department of Molecular Oncology and Leukemia Program Project, Research Institute for Radiation Biology and Medicine, Hiroshima University.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|October 29, 2009
Summary
Radiation exposure can cause acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). AML often arises quickly due to genetic changes, while MDS develops later, with epigenetic factors playing a role in both.
Area of Science:
- Hematology
- Radiation Oncology
- Cancer Genetics
Context:
- Radiation's link to leukemia was noted a century ago.
- Atomic bomb survivors showed high AML rates and later MDS/solid tumors.
- Therapy-related leukemias have distinct genetic origins.
Purpose:
- To differentiate the mechanisms and timelines of radiation-induced AML and MDS.
- To explore the roles of genetic chimeras and epigenetic changes.
- To understand the specific agents causing therapy-related myeloid malignancies.
Summary:
- Radiation-induced acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) differ in latency and etiology.
- De novo AML in survivors is linked to chimeric genes from translocations, while MDS is less associated with chimeras.
- Epigenetic changes are implicated in both, with specific therapies (topoisomerase II inhibitors, alkylating agents) causing distinct AML/MDS subtypes.
Impact:
- Clarifies the distinct pathogenic pathways of radiation-induced myeloid cancers.
- Informs risk assessment and potential preventative strategies for radiation exposure.
- Provides insights into the molecular basis of therapy-related myeloid neoplasms.
Related Concept Videos
02:59Biological Effects of Radiation
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...